or Try an Advanced Search...

    Technical Analysis for CAPR - Capricor Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 6.26 0.97% 0.06
    CAPR closed up 9.93 percent on Friday, May 17, 2024, on 1.94 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CAPR trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.97%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.97%
    Pocket Pivot Bullish Swing Setup 0.97%
    Above Upper BB Strength 0.97%
    Gapped Up Strength 0.97%
    Up 3 Days in a Row Strength 0.97%
    Upper Bollinger Band Touch Strength 0.97%
    20 DMA Support Bullish 10.99%
    Upper Bollinger Band Touch Strength 10.99%
    Crossed Above 20 DMA Bullish 17.45%
    Older End-of-Day Signals for CAPR ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace 19 minutes ago
    Up 3% 38 minutes ago
    Up 2% 43 minutes ago
    Up 1% about 1 hour ago
    2x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CAPR Chart by TradingView
    Basic chart:

    Profile

    Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics

    Is CAPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 17 Capricor Therapeutics stock rises, Oppenheimer initiates coverage at Outperform
    May 14 Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
    May 14 Capricor Therapeutics, Inc. (CAPR) Q1 2024 Earnings Call Transcript
    May 13 Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
    May 13 Capricor Therapeutics GAAP EPS of -$0.31 misses by $0.20, revenue of $4.91M misses by $4.79M
    May 13 Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 12 Capricor Therapeutics Q1 2024 Earnings Preview
    May 9 Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
    May 8 Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
    May 6 Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
    See more CAPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.2212
    52 Week Low 2.68
    Average Volume 388,369
    200-Day Moving Average 4.78
    50-Day Moving Average 5.93
    20-Day Moving Average 5.34
    10-Day Moving Average 5.49
    Average True Range 0.40
    RSI (14) 63.77
    ADX 15.72
    +DI 31.88
    -DI 17.64
    Chandelier Exit (Long, 3 ATRs) 5.33
    Chandelier Exit (Short, 3 ATRs) 5.89
    Upper Bollinger Bands 5.89
    Lower Bollinger Band 4.79
    Percent B (%b) 1.28
    BandWidth 20.58
    MACD Line -0.02
    MACD Signal Line -0.10
    MACD Histogram 0.0877
    Fundamentals Value
    Market Cap 190.92 Million
    Num Shares 30.8 Million
    EPS -1.16
    Price-to-Earnings (P/E) Ratio -5.34
    Price-to-Sales 8.72
    Price-to-Book 7.73
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.32
    Resistance 3 (R3) 7.30 6.92 7.13
    Resistance 2 (R2) 6.92 6.63 6.92 7.07
    Resistance 1 (R1) 6.56 6.46 6.74 6.57 7.01
    Pivot Point 6.17 6.17 6.26 6.18 6.17
    Support 1 (S1) 5.82 5.89 6.00 5.83 5.39
    Support 2 (S2) 5.43 5.71 5.44 5.33
    Support 3 (S3) 5.07 5.43 5.27
    Support 4 (S4) 5.08